## **Core Concept**
Tobacco-induced squamous cell carcinoma (SCC) is a type of cancer strongly associated with smoking and tobacco use. The carcinogenesis in tobacco-related SCC involves mutations in various genes due to the exposure to carcinogens present in tobacco smoke. Key genes often implicated include TP53, a tumor suppressor gene, and HRAS, a proto-oncogene.

## **Why the Correct Answer is Right**
The correct answer, **TP53 and HRAS** are commonly mutated in tobacco-related cancers, including squamous cell carcinoma. **TP53** mutations are among the most frequent alterations found in human cancers, including tobacco-related SCC, leading to loss of cell cycle regulation and apoptosis. **HRAS** mutations can lead to constitutive activation of signaling pathways promoting cell proliferation and survival. These mutations are critical in the development and progression of SCC.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might suggest a gene not commonly associated with tobacco-induced SCC mutations. Without a specific gene provided, it's hard to directly refute, but typically, mutations in **TP53** and **HRAS** are well-documented.
- **Option B:** Similarly, this could imply another gene not frequently implicated in the context of tobacco-induced SCC.
- **Option D:** This option might imply a gene frequently mutated in other types of cancers or in SCC not specifically related to tobacco use.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **TP53** mutations are highly prevalent in tobacco-related cancers, including squamous cell carcinomas. These mutations can lead to a loss of function of the p53 protein, which normally acts to prevent cancer formation by stopping cells with damaged DNA from dividing. This is a critical concept for understanding the molecular basis of tobacco-related carcinogenesis.

## **Correct Answer: D.**